Ischaemic heart disease mortality study among workers with occupational exposure to ammonium perfluorooctanoate

Occupational and Environmental Medicine

Volumn 66, Issue 10, 2009, Pages 699-703

  Sakr, Carine J ^a   Symons, J M ^a   Kreckmann, K H ^a   Leonard, R C ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERFLUOROOCTANOATE AMMONIUM; PERFLUOROOCTANOIC ACID; SURFACTANT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; WORK;

ADULT; AIR POLLUTANTS, OCCUPATIONAL; DELAWARE; EPIDEMIOLOGIC METHODS; FEMALE; FLUOROCARBONS; HUMANS; MALE; MYOCARDIAL ISCHEMIA; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; YOUNG ADULT;

EID: 70349404191     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oem.2008.041582     Document Type: Article

References (38)

1. Washburn ST, Bingman TS, Braithwaite SK, et al. Exposure assessment and risk characterization for perfluorooctanoate in selected consumer articles. Environ Sci Technol 2005;39:3904-3910
2. Lau C, Anitole K, Hodes C, et al. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 2007;99:366-394 (Pubitemid 351753056)
3. Pastoor TP, Lee KP, Perri MA, et al. Biochemical and morphological studies of ammonium perfluorooctanoate-induced hepatomegaly and peroxisome proliferation. Exp Mol Pathol 1987;47:98-109.
4. Haughom B, Spydevold O. The mechanism underlying the hypolipemic effect of perflurooctanoic acid (PFOA), perfluorooctanesulphonic acid (PFOSA), and clofibric acid. Biochim Biophys Acta 1992;1128:65-72.
5. Butenhoff JL, Costa G, Elcombe C, et al. Toxicity of ammonium perfluorooctanoate (APFO) in cynomolgus monkeys after 26 weeks of oral dosing. Toxicol Sci 2002;69:244-257
6. Kennedy GL, Butenhoff JL, Olsen GW, et al. The toxicology of perfluorooctanoate. Crit Rev Toxicol 2004;34:351-384
7. Olsen GW, Gilliland FD, Burlew MM, et al. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J Occup Environ Med 1998;40:614-622
8. Olsen GW, Burris JM, Burlew MM, et al. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 2003;45:260-270
9. Olsen GW, Burris JM, Ehresman DJ, et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 2007;115:1298-1305.
10. Sakr CJ, Kreckmann KH, Green JW, et al. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. J Occup Environ Med 2007;49:1086-1096
11. Sakr CJ, Leonard RC, Kreckmann KH, et al. Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J Occup Environ Med 2007;49:872-879
12. Leonard RC, Kreckmann KH, Sakr CJ, et al. Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann Epidemiol 2008;18:15-22.
13. Enterline PE. Not uniformly true for each cause of death. J Occup Med 1975;17:127-128
14. McMichael AJ. Standardized mortality ratio and the healthy worker effect: scratching below the surface. J Occup Med 1976;18:165-168
15. Parodi S, Gennaro V, Ceppi M, et al. Comparison bias and dilution effect in occupational cohort studies. Int J Occup Environ Health 2007;13:143-152 (Pubitemid 46988466)
16. Buchanich JM, Dolan DG, Marsh GM, et al. Underascertainment of deaths using social security records: a recommended solution to a little-known problem. Am J Epidemiol 2005;162:193-194
17. Kriebel D, Checkoway H, Pearce N. Exposure and dose modelling in occupational epidemiology. Occup Environ Med 2007;64:492-498 (Pubitemid 47020293)
18. Matanoski GM, Tao X. Styrene exposure and ischemic heart disease: a case-cohort study. Am J Epidemiol 2003;158:988-995 (Pubitemid 37413398)
19. Eisen EA, Bardin J, Gore R, et al. Exposure-response models based on extended follow-up of a cohort mortality study in the automobile industry. Scand J Work Environ Health 2001;27:240-249 (Pubitemid 32827575)
20. Schulgen G, Lausen B, Olsen J, et al. Outcome-oriented cutpoints in quantitative exposure. Am J Epidemiol 1994;120:172-184
21. Richardson DB, Loomis D. The impact of exposure categorization for grouped analyses of cohort data. Occup Environ Med 2004;61:930-935 (Pubitemid 39389354)
22. Malloy EJ, Miller KL, Eisen EA. Rectal cancer and exposure to metalworking fluids in the automobile manufacturing industry. Occup Environ Med 2007;64:244-249
23. Tolbert PE, Eisen EA, Pothier LJ, et al. Mortality studies of machining fluid exposure in the automobile industry II: risks associated with specific fluid types. Scand J Work Environ Health 1992;18:351-360
24. Friesen MC, Davies HW, Teschke K, et al. Impact of the specificity of the exposure metric on exposure-response relationships. Epidemiology 2007;18:88-94. (Pubitemid 46005913)
25. Barnett E, Halverson JA, Elmes GA, et al. Metropolitan and non-metropolitan trends in coronary heart disease mortality within Appalachia, 1980-1997. Ann Epidemiol 2000;10:370-379
26. Pell S, Fayerweather WE. Trends in the incidence of myocardial infarction and in associated mortality and morbidity in a large employed population, 1957-1983. N Engl J Med 1985;312:1005-1011
27. Huston SL, Lengerich EJ, Conlisk E, et al. Trends in ischemic heart disease death rates for blacks and whites - United States, 1981-1995. MMWR Morb Mort Wkly Rep 1998;47:945-949
28. Minino AM, Heron MP, Murphy SL, et al. Deaths: final data for 2004. National vital statistics reports volume55 number 19. Hyattesville, MD: National Center for Health Statistics, 2007. Available from http://www.cdc.gov/nchs/ data/nvsr/nvsr55/ nvsr55-19.pdf (accessed 13 July 2009).
29. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Committee. Circulation 2008;117:e25-e146.
30. Gilliland FD, Mandel JS. Mortality among employees of a perfluorooctanoic acid production plant. J Occup Med 1993;35:950-954 (Pubitemid 23285042)
31. Choi BCK. Definition, sources, magnitude, effect modifiers, and strategies of reduction of the healthy worker effect. J Occup Med 1992;34:979-988
32. Monson RR. Observations on the healthy worker effect. J Occup Med 1986;28:425-433
33. Arrighi HM, Hertz-Picciotto I. The evolving concept of the healthy worker survivor effect. Epidemiology 1994;5:189-196 (Pubitemid 24073393)
34. Hertz-Picciotto I, Arrighi HM, Hu SW. Does arsenic exposure increase the risk for circulatory disease? Am J Epidemiol 2000;151:174-181
35. Gilbert ES. Some confounding factors in the study of mortality and occupational exposures. Am J Epidemiol 1982;116:177-188
36. Checkoway H, Pearce NE, Kriebel D. Research methods in occupational epidemiology. 2nd edn. New York: Oxford University Press, 2004.
37. Bell DM, Fair MA, Elnicki DM, et al. Characteristics of West Virginians having myocardial infarction. South Med J 1998;91:1042-1046 (Pubitemid 28524387)
38. C8 Science Panel Studies. Worker follow-up study. Available from ttp://www. c8sciencepanel.org/studies.html#4 (accessed 13 July 2009).